Pipeline

At GSK, our pipeline is focused on unlocking the science of the immune system, human genetics, and advanced technologies to develop vaccines and specialty medicines.

Our products in development progress through three stages: phase I, phase II, and phase III/registrational. Each of these phases allows us to assess the safety and efficacy of our investigational products to eventually provide data to support applications for regulatory approval.

DISEASE STATES

ANEMIA OF CHRONIC KIDNEY DISEASE (CKD)
Phase 3

ASCEND (Anemia studies in CKD)

ASCEND-P: Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric

0 results - Use filter to search Pipeline